These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22619110)

  • 1. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.
    Li F; Zhai YP; Tang YM; Wang LP; Wan PJ
    Genes Chromosomes Cancer; 2012 Sep; 51(9):890-7. PubMed ID: 22619110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.
    Grand EK; Grand FH; Chase AJ; Ross FM; Corcoran MM; Oscier DG; Cross NC
    Genes Chromosomes Cancer; 2004 May; 40(1):78-83. PubMed ID: 15034873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
    Kim SY; Kim JE; Park S; Kim HK
    Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
    Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
    Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
    Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
    Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of four new translocations involving FGFR1 in myeloid disorders.
    Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
    Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
    Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature.
    Kim WS; Park SG; Park G; Jang SJ; Moon DS; Kang SH
    Acta Haematol; 2015; 133(1):101-5. PubMed ID: 25227135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
    Zhang WW; Habeebu S; Sheehan AM; Naeem R; Hernandez VS; Dreyer ZE; López-Terrada D
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):879-83. PubMed ID: 19829149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [8p11 myeloproliferative syndrome with CEP110-FGFR1 fusion in a patient].
    Chao H; Chen S; Zhou M; Lu X; Zhang X; Pan J; Wu C; Zhang R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):679-82. PubMed ID: 26418991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion.
    Dolan M; Cioc A; Cross NC; Neglia JP; Tolar J
    Pediatr Blood Cancer; 2012 Jul; 59(1):194-6. PubMed ID: 22106025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
    Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
    Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.
    Etienne A; Gelsi-Boyer V; Carbuccia N; Adélaïde J; Barba G; La Starza R; Murati A; Eclache V; Birg F; Birnbaum D; Mozziconacci MJ; Mecucci C; Chaffanet M
    Cancer Genet Cytogenet; 2007 Mar; 173(2):154-8. PubMed ID: 17321332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.
    Reiter A; Sohal J; Kulkarni S; Chase A; Macdonald DH; Aguiar RC; Gonçalves C; Hernandez JM; Jennings BA; Goldman JM; Cross NC
    Blood; 1998 Sep; 92(5):1735-42. PubMed ID: 9716603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
    Murati A; Arnoulet C; Lafage-Pochitaloff M; Adélaide J; Derré M; Slama B; Delaval B; Popovici C; Vey N; Xerri L; Mozziconacci MJ; Boulat O; Sainty D; Birnbaum D; Chaffanet M
    Int J Oncol; 2005 Jun; 26(6):1485-92. PubMed ID: 15870860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.
    Patnaik MM; Gangat N; Knudson RA; Keefe JG; Hanson CA; Pardanani A; Ketterling RP; Tefferi A
    Am J Hematol; 2010 Apr; 85(4):238-42. PubMed ID: 20143402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
    Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S; Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N
    Leuk Res; 2010 Oct; 34(10):e282-5. PubMed ID: 20594995
    [No Abstract]   [Full Text] [Related]  

  • 19. Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome.
    Agerstam H; Lilljebjörn H; Lassen C; Swedin A; Richter J; Vandenberghe P; Johansson B; Fioretos T
    Genes Chromosomes Cancer; 2007 Jul; 46(7):635-43. PubMed ID: 17394134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
    Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
    Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.